Roche wins CE mark for ApoE4 test
3 articles curated from biotech news
Roche secures CE mark for blood test to identify ApoE4 carriers
BioWorld (Clarivate)Mar 17, 2026Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease
PR Newswire - HealthMar 16, 2026Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease
PR Newswire - HealthMar 16, 2026
Want daily biotech news like this? Sign up free